TuHURA BIOSCIENCES, INC./NV Increase (Decrease) in Accounts Receivable
TuHURA BIOSCIENCES, INC./NV (HURA) reported Increase (Decrease) in Accounts Receivable of $0 for the 42-month period ending 2012-12-31, per its 10-Q filed 2013-01-18.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2013-01-18
- TuHURA BIOSCIENCES, INC./NV increase (decrease) in accounts receivable for the quarter ending 2012-12-31 was $0.00.
- TuHURA BIOSCIENCES, INC./NV increase (decrease) in accounts receivable for the quarter ending 2012-09-30 was $0.00, a 100.00% decline year-over-year.
- TuHURA BIOSCIENCES, INC./NV increase (decrease) in accounts receivable for the quarter ending 2012-06-30 was $0.00.
- TuHURA BIOSCIENCES, INC./NV increase (decrease) in accounts receivable for the quarter ending 2012-03-31 was $0.00.
- TuHURA BIOSCIENCES, INC./NV increase (decrease) in accounts receivable for fiscal 2012 was $5.00K.
- TuHURA BIOSCIENCES, INC./NV increase (decrease) in accounts receivable for fiscal 2011 was -$5.00K.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month | Increase (Decrease) in Accounts Receivable 30 month | Increase (Decrease) in Accounts Receivable 33 month | Increase (Decrease) in Accounts Receivable 36 month | Increase (Decrease) in Accounts Receivable 39 month | Increase (Decrease) in Accounts Receivable 42 month |
|---|---|---|---|---|---|---|---|---|---|
| 2012-12-31 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2013-01-18 | $0.00 10-Q · filed 2013-01-18 | $0.00 derived: sum of 3 quarters · filed 2013-01-18 | $0.00 derived: sum of 4 quarters · filed 2013-01-18 | $0.00 10-Q · filed 2013-01-18 | ||||
| 2012-09-30 | $0.00 10-Q/A · filed 2012-12-20 | $0.00 derived: sum of 2 quarters · filed 2012-12-20 | $0.00 derived: sum of 3 quarters · filed 2012-12-20 | $0.00 derived: sum of 4 quarters · filed 2013-01-18 | $0.00 10-Q/A · filed 2012-12-20 | ||||
| 2012-06-30 | $0.00 10-K/A · filed 2012-12-20 | $0.00 derived: sum of 2 quarters · filed 2012-12-20 | $0.00 derived: sum of 3 quarters · filed 2013-01-18 | $5.00K 10-K/A · filed 2012-12-20 | $0.00 10-K/A · filed 2012-12-20 | ||||
| 2012-03-31 | $0.00 derived: 10-Q/A 9 month − 10-Q 6 month · filed 2012-06-05 | $0.00 derived: sum of 2 quarters · filed 2013-01-18 | $5.00K 10-Q/A · filed 2012-06-05 | $0.00 derived: sum of 4 quarters · filed 2013-01-18 | $0.00 10-Q/A · filed 2012-06-05 | ||||
| 2011-12-31 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2013-01-18 | $5.00K 10-Q · filed 2013-01-18 | $0.00 derived: sum of 3 quarters · filed 2013-01-18 | $0.00 derived: sum of 4 quarters · filed 2013-01-18 | $0.00 10-Q · filed 2012-02-07 | ||||
| 2011-09-30 | $5.00K 10-Q/A · filed 2012-12-20 | $0.00 derived: sum of 2 quarters · filed 2012-12-20 | $0.00 derived: sum of 3 quarters · filed 2012-12-20 | ||||||
| 2011-06-30 | -$5.00K 10-K/A · filed 2012-12-20 | -$5.00K derived: sum of 2 quarters · filed 2012-12-20 | -$5.00K 10-K/A · filed 2012-12-20 | ||||||
| 2011-03-31 | $0.00 derived: 10-Q/A 9 month − 10-Q 6 month · filed 2012-06-05 | $0.00 10-Q/A · filed 2012-06-05 | |||||||
| 2010-12-31 | $0.00 10-Q · filed 2012-02-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |